Pascal Soriot, AstraZeneca CEO (Raphael Lafargue/Abaca/Sipa USA; Sipa via AP Images)
Covid-19 roundup: Scientists pull pre-print with inflated incidence of myocarditis post mRNA vaccine; AstraZeneca seeks EUA for long-acting antibody
Canadian scientists recently withdrew an alarming pre-print manuscript that mistakenly said the incidence of the heart condition myocarditis was a lot more frequent than actually …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.